Health Catalyst Price to Free Cash Flow Ratio 2018-2025 | HCAT
Historical price to free cash flow ratio values for Health Catalyst (HCAT) since 2018.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Health Catalyst Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-14 | 2.27 | 0.00 | |
| 2025-06-30 | 3.77 | $-0.38 | 0.00 |
| 2025-03-31 | 4.53 | $-0.22 | 0.00 |
| 2024-12-31 | 7.07 | $-0.02 | 0.00 |
| 2024-09-30 | 8.14 | $-0.27 | 0.00 |
| 2024-06-30 | 6.39 | $-0.30 | 0.00 |
| 2024-03-31 | 7.53 | $-0.53 | 0.00 |
| 2023-12-31 | 9.26 | $-0.82 | 0.00 |
| 2023-09-30 | 10.12 | $-0.77 | 0.00 |
| 2023-06-30 | 12.50 | $-1.07 | 0.00 |
| 2023-03-31 | 11.67 | $-1.05 | 0.00 |
| 2022-12-31 | 10.63 | $-0.93 | 0.00 |
| 2022-09-30 | 9.70 | $-0.89 | 0.00 |
| 2022-06-30 | 14.49 | $-0.74 | 0.00 |
| 2022-03-31 | 26.13 | $-0.67 | 0.00 |
| 2021-12-31 | 39.62 | $-0.85 | 0.00 |
| 2021-09-30 | 50.01 | $-0.84 | 0.00 |
| 2021-06-30 | 55.51 | $-0.81 | 0.00 |
| 2021-03-31 | 46.77 | $-0.65 | 0.00 |
| 2020-12-31 | 43.53 | $-0.89 | 0.00 |
| 2020-09-30 | 36.60 | $-1.70 | 0.00 |
| 2020-06-30 | 29.17 | $-2.33 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.160B | $0.307B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $11.897B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Inspire Medical Systems (INSP) | United States | $2.509B | 41.51 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $1.978B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.012B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |